West Pharmaceutical Services Aktie

241,21USD -2,54USD -1,04%
West Pharmaceutical Services für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 864330 / ISIN: US9553061055

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 10 065 10 700 10 600 10 600 10 800
Umsatz pro Mitarbeiter in Mio. EUR 0,28 0,27 0,28 0,27 0,28

Bilanz (in Mio. USD) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 1 742 1 920 1 936 1 538 1 978
Summe Anlagevermögen 1 572 1 697 1 893 2 105 2 292
Summe Aktiva 3 314 3 617 3 830 3 643 4 270

Bilanz (in Mio. USD) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 978 932 949 961 1 094
Summe Eigenkapital 2 335 2 685 2 881 2 682 3 176
Summe Passiva 3 314 3 617 3 830 3 643 4 270

Adresse

530 Herman O. West Drive, 19341-1147 Exton
Telefon +1 (610) 594-2900
Internet http://www.westpharma.com

Management

Annette F. Favorite
Chief Human Resources Officer & Senior VP
Chad R. Winters
Chief Accounting Officer & VP-Finance
Deborah L. V. Keller
Independent Director
Donald A. McMillan
Vice President-Enterprise Business Systems
Douglas A. Michels
Independent Director
Eric Mark Green
Chairman, President & Chief Executive Officer
Janet Brutschea Haugen
Independent Director
Kathy dePadua
Chief Quality & Regulatory Officer, Senior VP
Mark A. Buthman
Independent Director
Molly E. Joseph
Independent Director
Myla P. Lai-Goldman
Independent Director
Paolo Pucci
Lead Independent Director
Quintin John Lai
Vice President-Corporate Development & Strategy
Robert F. Friel
Independent Director
Robert W. McMahon
Chief Financial Officer & Senior Vice President
Rudy Poussot
Senior VP-Strategy & Corporate Development
Shane Campbell
Chief Proprietary Segment Officer & Senior VP
Stephen H. Lockhart
Independent Director
Thomas W. Hofmann
Independent Director
William F. Feehery
Independent Director